Understanding complex rheumatological conditions requires both medical expertise and compassion. In this exclusive interview, Dr. Aruna Caldera, Consultant Rheumatologist, speaks with Zanita Careem ...

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden reduction through 2 years 4D-150 continues to be well ...

Millions of people with type 2 diabetes who take semaglutide, the active ingredient in Ozempic and Wegovy, can draw some ...

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of ...

Commonwealth Games-bound Derbyshire boxer Chantelle Reid reflects on how a degenerative back problem delayed her career and ...

A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...

Results point to potential to restore vision with drugs, non-invasively, reversibly, via a mechanism that is independent to ...

Jacqueline Tabler discusses the role of connective tissues, highlighting the complex relationship between genetics, ...

Although advances in DMARDs have improved outcomes, some people with axSpA experience an inadequate response to therapy.

A new diffusion MRI approach offers a glimpse of the anomalies of cellular architecture underlying basal ganglia degeneration in Huntington’s disease.

Many people automatically think of Alzheimer’s disease when they hear the word “dementia.” While Alzheimer’s is the most common type, there are multiple kinds of dementia. Below, doctors explain ...

The interplay between nutrition, gut microbiota, and age-related chronic-degenerative diseases represents a rapidly evolving ...